Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/194757
Title: Does virtual reality increase the efficacy of psychotherapy for young adults with mild-to-moderate depression? A study protocol for a multicenter randomized clinical trial
Author: Montesano del Campo, Adrián
Medina Alcaraz, Juan Carlos
Paz, Clara
García Mieres, Helena
Niño Robles, Noelia
García Grau, Eugeni
Cañete Crespillo, Josep
García Gutiérrez, Alejandro
Alabèrnia Segura, Miquel
Feixas i Viaplana, Guillem
Keywords: Psicoteràpia
Depressió psíquica
Realitat virtual
Assaigs clínics
Psychotherapy
Mental depression
Virtual reality
Clinical trials
Issue Date: 13-Dec-2021
Publisher: BioMed Central
Abstract: Background: The improvement of psychological treatments for depression in young adults is a pressing issue highlighted in the literature. Its relevance is determined not only because young adults are underrepresented in research, but also to prevent chronic severe mental health disorders later in life. Engagement is considered a key factor for a good therapeutic outcome, especially among young patients. In this sense, virtual reality could be particularly suited to engage young adults in the therapy process. This project aims to improve the psychological treatment of mild-to-moderate depression in young adults by testing out the efficacy of virtual reality-enhanced personal construct therapy (PCT-VR), as compared to personal construct therapy alone (PCT) and to the reference standard cognitive behavioral therapy (CBT). In contrast to CBT, PCT neither educates patients about depression nor gives them directions on the changes to be made in their dysfunctional behaviors or cognitions. Rather, PCT explores the coherence (or conflicts) of thoughts and behaviors with respect to the person's sense of identity and focuses on meaning-making processes. Methods: The efficacy of this innovative intervention (PCT-VR) will be compared to PCT and to CBT in a randomized clinical trial. The study includes an appraisal of therapists' adherence and independent assessments to preserve internal validity. The Beck Depression Inventory-II is the primary outcome measure for calculating both statistical and clinical significance, but other outcomes will also be assessed (e.g., functioning, well-being, anxiety, stress) at pre- and post-therapy and at 6-month follow-up. The trial will be conducted in a naturalistic context, mostly at the usual health care center of each patient. A sample of 225 participants is targeted to reach enough statistical power to accomplish the goals of the study. Discussion: We expect that providing evidence for PCT-VR will widen the repertoire of evidence-based technology-based psychotherapeutic interventions for young adults and contribute to the prevention of deteriorating courses of the disorder.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s13063-021-05809-1
It is part of: Trials, 2021, vol. 22, p. 916
URI: http://hdl.handle.net/2445/194757
Related resource: https://doi.org/10.1186/s13063-021-05809-1
ISSN: 1745-6215
Appears in Collections:Articles publicats en revistes (Psicologia Clínica i Psicobiologia)

Files in This Item:
File Description SizeFormat 
730746.pdf734.17 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons